1179 related articles for article (PubMed ID: 19714720)
41. Management of hepatocellular carcinoma: an update.
Bruix J; Sherman M;
Hepatology; 2011 Mar; 53(3):1020-2. PubMed ID: 21374666
[No Abstract] [Full Text] [Related]
42. American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.
Reddy KR; Beavers KL; Hammond SP; Lim JK; Falck-Ytter YT;
Gastroenterology; 2015 Jan; 148(1):215-9; quiz e16-7. PubMed ID: 25447850
[No Abstract] [Full Text] [Related]
43. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.
Marcellin P; Gane E; Buti M; Afdhal N; Sievert W; Jacobson IM; Washington MK; Germanidis G; Flaherty JF; Aguilar Schall R; Bornstein JD; Kitrinos KM; Subramanian GM; McHutchison JG; Heathcote EJ
Lancet; 2013 Feb; 381(9865):468-75. PubMed ID: 23234725
[TBL] [Abstract][Full Text] [Related]
44. Routine hepatitis B virus DNA testing in human immunodeficiency virus-infected patients with positive hepatitis B core antibody but negative hepatitis B surface antigen is not justified by current evidence.
Núñez M
Hepatology; 2010 Mar; 51(3):1087-8. PubMed ID: 19960553
[No Abstract] [Full Text] [Related]
45. Sexually transmitted diseases treatment guidelines, 2015.
Workowski KA; Bolan GA;
MMWR Recomm Rep; 2015 Jun; 64(RR-03):1-137. PubMed ID: 26042815
[TBL] [Abstract][Full Text] [Related]
46. Management of patients with hepatitis B who require immunosuppressive therapy.
Hwang JP; Lok AS
Nat Rev Gastroenterol Hepatol; 2014 Apr; 11(4):209-19. PubMed ID: 24247262
[TBL] [Abstract][Full Text] [Related]
47. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.
Terrault NA; Lok ASF; McMahon BJ; Chang KM; Hwang JP; Jonas MM; Brown RS; Bzowej NH; Wong JB
Hepatology; 2018 Apr; 67(4):1560-1599. PubMed ID: 29405329
[No Abstract] [Full Text] [Related]
48. Microscopic colitis.
Pardi DS; Kelly CP
Gastroenterology; 2011 Apr; 140(4):1155-65. PubMed ID: 21303675
[TBL] [Abstract][Full Text] [Related]
49. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer.
Lieberman DA; Rex DK; Winawer SJ; Giardiello FM; Johnson DA; Levin TR
Gastroenterology; 2012 Sep; 143(3):844-857. PubMed ID: 22763141
[No Abstract] [Full Text] [Related]
50. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.
Sarin SK; Kumar M; Lau GK; Abbas Z; Chan HL; Chen CJ; Chen DS; Chen HL; Chen PJ; Chien RN; Dokmeci AK; Gane E; Hou JL; Jafri W; Jia J; Kim JH; Lai CL; Lee HC; Lim SG; Liu CJ; Locarnini S; Al Mahtab M; Mohamed R; Omata M; Park J; Piratvisuth T; Sharma BC; Sollano J; Wang FS; Wei L; Yuen MF; Zheng SS; Kao JH
Hepatol Int; 2016 Jan; 10(1):1-98. PubMed ID: 26563120
[TBL] [Abstract][Full Text] [Related]
51. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.
Schweitzer A; Horn J; Mikolajczyk RT; Krause G; Ott JJ
Lancet; 2015 Oct; 386(10003):1546-55. PubMed ID: 26231459
[TBL] [Abstract][Full Text] [Related]
52. American College of Gastroenterology guideline: management of acute pancreatitis.
Tenner S; Baillie J; DeWitt J; Vege SS;
Am J Gastroenterol; 2013 Sep; 108(9):1400-15; 1416. PubMed ID: 23896955
[TBL] [Abstract][Full Text] [Related]
53. Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
Huang H; Li X; Zhu J; Ye S; Zhang H; Wang W; Wu X; Peng J; Xu B; Lin Y; Cao Y; Li H; Lin S; Liu Q; Lin T
JAMA; 2014 Dec; 312(23):2521-30. PubMed ID: 25514302
[TBL] [Abstract][Full Text] [Related]
54. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America.
Stevens DL; Bisno AL; Chambers HF; Dellinger EP; Goldstein EJ; Gorbach SL; Hirschmann JV; Kaplan SL; Montoya JG; Wade JC
Clin Infect Dis; 2014 Jul; 59(2):147-59. PubMed ID: 24947530
[TBL] [Abstract][Full Text] [Related]
55. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.
Lok AS; Liang RH; Chiu EK; Wong KL; Chan TK; Todd D
Gastroenterology; 1991 Jan; 100(1):182-8. PubMed ID: 1983820
[TBL] [Abstract][Full Text] [Related]
56. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.
Bacon BR; Adams PC; Kowdley KV; Powell LW; Tavill AS;
Hepatology; 2011 Jul; 54(1):328-43. PubMed ID: 21452290
[No Abstract] [Full Text] [Related]
57. Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis.
Lok AS; McMahon BJ; Brown RS; Wong JB; Ahmed AT; Farah W; Almasri J; Alahdab F; Benkhadra K; Mouchli MA; Singh S; Mohamed EA; Abu Dabrh AM; Prokop LJ; Wang Z; Murad MH; Mohammed K
Hepatology; 2016 Jan; 63(1):284-306. PubMed ID: 26566246
[TBL] [Abstract][Full Text] [Related]
58. American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.
Perrillo RP; Gish R; Falck-Ytter YT
Gastroenterology; 2015 Jan; 148(1):221-244.e3. PubMed ID: 25447852
[No Abstract] [Full Text] [Related]
59. Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis.
Mejia R; Nutman TB
Curr Opin Infect Dis; 2012 Aug; 25(4):458-63. PubMed ID: 22691685
[TBL] [Abstract][Full Text] [Related]
60. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.
Chey WD; Leontiadis GI; Howden CW; Moss SF
Am J Gastroenterol; 2017 Feb; 112(2):212-239. PubMed ID: 28071659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
